https://doi.org/10.5812/jkums-154363

Prevalence of Acute and Chronic Toxoplasma gondii Infection in the Iranian Women of Reproductive Age: A Systematic Review and Meta-Analysis of Data Published Between 2010 - 2024

authors:

avatar Forouzan Rahmani ORCID 1 , avatar Shabnam Hasani ORCID 2 , avatar Masoumeh Sadat Mousavi ORCID 3 , avatar Leila Kianfard ORCID 4 , *

Department of Anatomical Sciences and Histology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
Faculty of Veterinary Medicine, Urmia Branch, Islamic Azad University, Urmia, Iran
Department of Public Health, Eghlid Branch, Islamic Azad University, Eghlid, Iran
Department of Health Education and Health Promotion, Tarbiat Modares University, Tehran, Iran
Journal of Kermanshah University of Medical Sciences: Vol.29, issue 1; e154363
published online: January 19, 2025
article type: Systematic Review
received: September 6, 2024
revised: January 1, 2025
accepted: January 8, 2025

How To Cite? Rahmani F, Hasani S, Mousavi M S, Kianfard L. Prevalence of Acute and Chronic Toxoplasma gondii Infection in the Iranian Women of Reproductive Age: A Systematic Review and Meta-Analysis of Data Published Between 2010 - 2024. J Kermanshah Univ Med Sci. 2025;29(1):e154363. https://doi.org/10.5812/jkums-154363.

Abstract

Context:

Toxoplasma gondii remains a global concern, especially in developing countries. This parasite is particularly important in women of childbearing age due to its increased risk of miscarriage and serious complications in the newborn.

Objectives:

This systematic review and meta-analysis was conducted to determinet the serum prevalence of acute and chronic T. gondii infection in women of reproductive age in Iran.

Methods:

The systematic search process was carried out from January 2010 to July 2024 through four English databases (PubMed, Scopus, Web of Science, and Science Direct) and two Persian databases (Magiran and SID) as well as Google Scholar as a specialized search engine for the article. Meta-analysis analysis was performed using a random effects model. Prevalence estimates and 95% confidence intervals were calculated for each study. Heterogeneity was evaluated using the I2 statistic. Egger and Begg's test was also used to assess the publication bias.

Results:

A total of 869 records were retrieved, resulting in 28 studies including 13,177 individuals of reproductive age included in the meta-analysis for T. gondii-specific IgG and/or IgM antibodies. The seroprevalence of IgG and IgM antibody serum in women is 29% (95% CI: 23% - 34%) and 4% (95% CI:3% - 5%) respectively. Egger's test results (P = 0.001) showed publication bias.

Conclusions:

The prevalence of chronic (IgG) and acute infection (IgM) T. gondii in women of reproductive age in Iran is relatively high. Therefore, there is an urgent need for education to increase women's awareness.

1. Context

Toxoplasma gondii remains a global concern, especially in developing countries. It is a zoonotic disease between humans and animals (1). The definitive host (feline) causes environmental pollution by releasing oocysts. High-risk groups, including pregnant women and immunocompromised people. Humans are infected with this parasite through the consumption of half-cooked meat, unpasteurized milk, direct or indirect contact with environmental oocysts, vertical transmission during pregnancy, blood transfusion, and organ transplantation (2).

The global prevalence of T. gondii varies (1% - 100%) (3, 4) under the influence of climatic conditions, host susceptibility and soil humidity, health conditions, eating habits, and general awareness level. The prevalence of contamination in the Middle East is approximately 30% to 50% (5), 27.8 % in Saudi Arabia (1), and 58.3 % in Turkiye (6).

This parasite is very important in women of reproductive age because it can cross the placental barrier during pregnancy, this infection in the first and second trimester of pregnancy can cause consequences such as low birth weight, hydrocephalus, intracranial calcifications, and vertinochoroiditis in newborns (7). T Specifically, 15% of premature abortions and 66% of late miscarriages are attributed to infections, considering the importance of having children and the youth of the population, this issue is very important (1).

2. Objectives

Considering the important role of T. gondii infection in neonatal complications as well as miscarriage (8), the present study was conducted to determine the serum prevalence of acute and chronic T. gondii infection in women of reproductive age in Iran.

3. Methods

This study, a systematic review and meta-analysis across Iran, was designed and implemented to evaluate the prevalence of serum antibiotics in women of reproductive age. This meta-analysis study was conducted according to the guidelines and protocol of meta-analysis (PRISMA) (9), and its protocol was registered in PROSPERO.

3.1. Search Strategy

The systematic search process was carried out from January 2010 to July 2024 through four English databases (PubMed, Scopus, Web of Science, and Science Direct) and two Persian databases (Magiran and SID) as well as Google Scholar as a specialized search engine for the article. using the following keywords: ("Toxoplasma" OR "Toxoplasma gondii" OR "T. gondii" OR "toxoplasmosis") and ("prevalence" OR "seroprevalence" OR "epidemiology") and ("Reproductive age " OR " Women " OR "Students" OR, childbearing Age " "or "Newly Married") and ("Iran" or "Islamic Republic of Iran").

3.2. Eligibility Criteria, Study Selection, and Data Extraction

After collecting the documents and articles, their specifications and abstracts were entered into the reference writing software, and duplicates were removed by using this software as well as re-reading the titles. In the next step, by reviewing the titles and abstracts, studies unrelated to the purpose of this research were excluded, and then from among the remaining studies, referring to the full text of the article, it was ensured that it was related to the purpose of the present study, and irrelevant items were removed. the reference list of specified studies was examined to find more related studies. In addition, to access the articles whose full text was not available through the databases, contact was made with the corresponding authors via e-mail to receive the full text of the articles. Inclusion criteria include: (1) Studies published in English or Farsi from January 2010 to July 2024; (2) all primary studies (cross-sectional-analytical and case-control) on the prevalence of T. gondii in women; (3) original articles with a full bibliography English and Farsi languages; (4) studies whose information (sample size and number of positive cases; (5) studies conducted only on humans.

3.3. Meta-Analysis

Meta-analysis analysis was performed using random effects model (10). The random effects model was used to estimate the prevalence and 95% confidence intervals. The weight of each study was calculated and the heterogeneity of studies was checked using Cochran's test (with a significance level less than 0.1) and its combination using the I2 statistic (with a significance level greater than 50%) (11). Egger and Begg's test was also used to evaluate the publication bias (12).

3.4. Quality Assessment

Study quality was assessed using the Newcastle-Ottawa scale (13).

4. Results

As shown in Figure 1, we identified 869 retrieved records in the database search, and after removing duplicates and irrelevant items, 28 studies were finally included in the meta-analysis (Figure 1). Table 1 shows the characteristics of the studies reported in the systematic review and meta-analysis.

PRISMA graph of data retrieved from various databases based on inclusion and exclusion criteria
PRISMA graph of data retrieved from various databases based on inclusion and exclusion criteria
Figure 1.

PRISMA graph of data retrieved from various databases based on inclusion and exclusion criteria

Table 1.

Characteristics of the Selected Studies

StudyYearPlace of StudyGroupMethodType of StudyNPositive IgGPositive IgM
Salehi et al. (14)2022MashhadReproductive ageELISACross-sectional417808
Zeinali et al. (15)2023Northwest of IranAbortedELISACross-sectional215703
Elyasi and Souizi (16)2023Razavi KhorasanNewly marriedELISACross-sectional8516-
Nabizadeh et al. (17)2022TabrizReproductive ageELISACross-sectional272672210
Saki et al. (18)2021KhuzestanAbortedELISACross-sectional48012324
Rahimi‑Esboei et al. (19)2021MazandaranReproductive ageELISACross-sectional50013321
Kalantari et al. (20)2020FarsStudentsELISACross-sectional504585
Naeini et al. (21)2019Chaharmahal and Bakhtiari-ELISACross-sectional20131
Soltani et al. (22)2018Southwest of Iran-ELISACross-sectional25313918
Matin et al. (23)2017ArdabilAbortedELISACross-sectional20010710
Sharif et al. (24)2016MazandaranELISACross-sectional1178662
Tavakoli Kareshk et al. (25)2016KermanChildbearing ageELISACross-sectional300386
Mojadadi et al. (26)2016SabzevarStudentsELISACross-sectional137180
Kamran et al. (27)2015IlamHigh school girlsELISACross-sectional26055
Saki et al. (28)2015AhvazAbortedELISACross-sectional130341
Hooshyar et al. (29)2015Kashan-ELISACross-sectional4341237
Davami et al. (30)2014JahromNewly marriedELISACross-sectional403528
Fallah et al. (31)2014AjabshirHigh schoolELISACross-sectional4028866
Rajaii et al. (32)2013Northwest Iranchildbearing womenELISACross-sectional1659898-
Davami et al. (30)2013JahromYoung womenELISACross-sectional4035213
Maraghi et al. (33)2013AbadanStudentsELISACross-sectional2402829
Mostafavi et al. (34)2012IsfahanChildbearing ageELISACross-sectional217103-
Heidari et al. (35)2011GonabadHigh schoolELISACross-sectional240340
Mostafavi et al. (36)2011Isfahan-ELISACross-sectional300109-
Khazaei et al. (37)2011ZahedanBefore marriageELISACross-sectional280-15
Hashemi and Saraei (38)2010QazvinBefore marriageELISACross-sectional400136-
Fouladvand et al. (39)2010BushehrHigh schoolELISACross-sectional4911147
Fouladvand (40)2010BushehrBefore marriageELISACross-sectional3037110

The results of the study showed that the prevalence of IgG and IgM antibody serum in women is 0.29 (95% CI: 0.23 - 0.34) (Figure 2A) and 0.04 (95% CI: 0.03 - 0.05) respectively (Figure 2B). Egger's test results (P = 0.001) showed publication bias. A funnel plot for detecting publication bias is shown in Figure 3.

Forest plot of meta-analysis showing Toxoplasma gondii seroprevalence in women of reproductive age A, IgG; B, IgM.
Forest plot of meta-analysis showing Toxoplasma gondii seroprevalence in women of reproductive age A, IgG; B, IgM.
Figure 2.

Forest plot of meta-analysis showing Toxoplasma gondii seroprevalence in women of reproductive age A, IgG; B, IgM.

Funnel plot to detect publication bias
Funnel plot to detect publication bias
Figure 3.

Funnel plot to detect publication bias

5. Discussion

One of the important challenges of T. gondii infection is fetal and neonatal complications, and there is a need for strategies to reduce this infection in women of reproductive age (41). Therefore, it is very important to investigate the contamination of women of reproductive age. Therefore, this current systematic review and meta-analysis was conducted to estimate the prevalence of T. gondii infection in women of reproductive age in Iran.

The present meta-analysis was performed using 28 published serological studies, with a sample size of 13,177 people. In this study, the serum prevalence of IgG T. gondii in reproductive age women is 29% (95% CI = 23% - 34%), which is consistent with the meta-analysis study conducted in Saudi Arabia 27.8% (95% CI = 20.6% - 36.3%) (1). But compared to other countries around Iran, Iraq 52.6% (1), Turkey 58.3% (6), and a study conducted in Iran by Mizani 43% between 1994 - 2017 (42), it is lower this could be due to increased awareness and preventive measures against this parasite.

The seroprevalence of IgM in this study was 4% (95% CI = 3% - 5%), which is higher than the meta-analysis study conducted in Turkey (1%) (6), blood donors in Iran (1.4%) (43). IgM indicates the acute form of T. gondii infection (instantaneous prevalence) in a way that it increases in the first week after exposure and then decreases (44) while IgG indicates a chronic infection (lifelong prevalence). What is important for preventing the problems and complications of T. gondii is the prevalence of the acute form of the disease. Governments should seek to reduce its prevalence in women of childbearing age (45).

5.1. Strengths and Weaknesses

This study is the first meta-analysis that investigates the prevalence of acute and chronic T. gondii infection in women of reproductive age in Iran.

The most important limitations of this study: In this meta-analysis, the prevalence of T. gondii seroprevalence was only done in 18 provinces, and there were few studies in other provinces. Also, gray literature was not examined in this meta-analysis, the non-reporting of risk factors in many studies that did not allow meta-analysis of risk factors and the fact that in this study we only examined women of reproductive age and pregnant women were excluded from the study.

5.2. Suggestions

It is recommended that a comprehensive systematic review meta-analysis study be conducted in the entire Iranian general population to obtain a comprehensive estimate of the overall prevalence in the general population and to compare the prevalence rates in different population subgroups.

5.3. Conclusions

The results of this study showed that the prevalence of chronic (IgG) and acute infection (IgM) T. gondii in women of reproductive age in Iran is relatively high. However, considering the young population in Iran and the increased chance of fetal loss in pregnant women with the acute form of this infection, there is an urgent need for education about the complications of this infection, the ways of transmission and its prevention to increase women's awareness.

References

  • 1.

    Alzaheb RA. Seroprevalence of Toxoplasma gondii and its associated risk factors among women of reproductive age in Saudi Arabia: a systematic review and meta-analysis. Int J Womens Health. 2018;10:537-44. [PubMed ID: 30288126]. [PubMed Central ID: PMC6159794]. https://doi.org/10.2147/IJWH.S173640.

  • 2.

    Kalantari N, Gorgani-Firouzjaee T, Moulana Z, Chehrazi M, Ghaffari S. Toxoplasma gondii infection and spontaneous abortion: A systematic review and meta-analysis. Microb Pathog. 2021;158:105070. [PubMed ID: 34186117]. https://doi.org/10.1016/j.micpath.2021.105070.

  • 3.

    Iddawela D, Vithana SMP, Ratnayake C. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study. BMC Public Health. 2017;17(1):930. [PubMed ID: 29202747]. [PubMed Central ID: PMC5716377]. https://doi.org/10.1186/s12889-017-4941-0.

  • 4.

    Munoz-Zanzi CA, Fry P, Lesina B, Hill D. Toxoplasma gondii oocyst-specific antibodies and source of infection. Emerg Infect Dis. 2010;16(10):1591-3. [PubMed ID: 20875286]. [PubMed Central ID: PMC3294384]. https://doi.org/10.3201/eid1610.091674.

  • 5.

    Rostami A, Riahi SM, Esfandyari S, Habibpour H, Mollalo A, Mirzapour A, et al. Geo-climatic factors and prevalence of chronic toxoplasmosis in pregnant women: A meta-analysis and meta-regression. Environ Pollut. 2021;288:117790. [PubMed ID: 34329056]. https://doi.org/10.1016/j.envpol.2021.117790.

  • 6.

    Yentur Doni N, Simsek Z, Gurses G, Yildiz Zeyrek F, Demir C. Prevalence and associated risk factors of Toxoplasma gondii in female farmworkers of southeastern Turkey. J Infect Dev Ctries. 2015;9(1):87-93. [PubMed ID: 25596576]. https://doi.org/10.3855/jidc.5824.

  • 7.

    Rostami A, Riahi SM, Contopoulos-Ioannidis DG, Gamble HR, Fakhri Y, Shiadeh MN, et al. Acute Toxoplasma infection in pregnant women worldwide: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2019;13(10). e0007807. [PubMed ID: 31609966]. [PubMed Central ID: PMC6822777]. https://doi.org/10.1371/journal.pntd.0007807.

  • 8.

    Mulu Gelaw Y, Worku Dagnew G, Degu Alene G, Gangneux JP, Robert-Gangneux F. Toxoplasma gondii seroprevalence among pregnant women in Africa: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2024;18(5). e0012198. [PubMed ID: 38781272]. [PubMed Central ID: PMC11152313]. https://doi.org/10.1371/journal.pntd.0012198.

  • 9.

    Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. [PubMed ID: 25554246]. [PubMed Central ID: PMC4320440]. https://doi.org/10.1186/2046-4053-4-1.

  • 10.

    Lee YH. An overview of meta-analysis for clinicians. Korean J Intern Med. 2018;33(2):277-83. [PubMed ID: 29277096]. [PubMed Central ID: PMC5840596]. https://doi.org/10.3904/kjim.2016.195.

  • 11.

    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60. [PubMed ID: 12958120]. [PubMed Central ID: PMC192859]. https://doi.org/10.1136/bmj.327.7414.557.

  • 12.

    Egger M, Smith GD. Misleading meta-analysis. BMJ. 1995;310(6982):752-4. [PubMed ID: 7711568]. [PubMed Central ID: PMC2549158]. https://doi.org/10.1136/bmj.310.6982.752.

  • 13.

    Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014;14:45. [PubMed ID: 24690082]. [PubMed Central ID: PMC4021422]. https://doi.org/10.1186/1471-2288-14-45.

  • 14.

    Salehi M, Nasimi A, Ghasemi H, Nezami H, Hassanzadeh HF, Fani M. Seroprevalence of TORCH Syndrome Among Women of Reproductive Age in Mashhad, Northeast of Iran. Int Med Today. 2022;28(4):530-41. https://doi.org/10.32598/hms.28.4.3850.1.

  • 15.

    Zeinali S, Khademvatan S, Jafari R, Vazifekhah S, Yousefi E, Behroozi-Lak T. Prevalence and risk factors of Toxoplasma gondii infection among women with miscarriage and their aborted fetuses in the northwest of Iran. PLoS One. 2023;18(10). e0283493. [PubMed ID: 37883415]. [PubMed Central ID: PMC10602335]. https://doi.org/10.1371/journal.pone.0283493.

  • 16.

    Elyasi H, Souizi B. [Seroepidemiology of toxoplasmosis and its risk factors in newly married women of Jovin city (Razavi Khorasan) in 1400]. J Zoonosis. 2022;2(2):30-40. FA.

  • 17.

    Nabizadeh E, Ghotaslou A, Salahi B, Ghotaslou R. The Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, and Toxoplasma gondii Antibodies in Prepregnancy and Reproductive-Age Women in Tabriz, Iran. Infect Dis Obstet Gynecol. 2022;2022:4490728. [PubMed ID: 35046632]. [PubMed Central ID: PMC8763548]. https://doi.org/10.1155/2022/4490728.

  • 18.

    Saki J, Zamanpour M, Najafian M, Mohammadpour N, Foroutan M. Detection of Acute and Chronic Toxoplasma gondii Infection among Women with History of Abortion in the Southwest of Iran. J Parasitol Res. 2021;2021:6693070. [PubMed ID: 34765259]. [PubMed Central ID: PMC8577945]. https://doi.org/10.1155/2021/6693070.

  • 19.

    Rahimi‑Esboei B, Rahimi MT, Ghorbani A, Mahdavi S. Genetic characterization of Toxoplasma gondii in women of reproductive age in the North of Iran. J Nurs Midwifery Sci. 2021;8(2). e140754. https://doi.org/10.4103/jnms.jnms_104_20.

  • 20.

    Kalantari M, Asgari Q, Rostami K, Naderi S, Mohammadpour I, Yousefi M, et al. Molecular and serological evaluation of Toxoplasma gondii among female university students in Mamasani district, Fars province, southern Iran. J Health Sci Surveillance Sys. 2020;8(2):75-80.

  • 21.

    Naeini KM, Soureshjani EH, Jafari M, Parchami S, Karimi G, Abdizadeh R. Prevalence of Toxoplasma gondii infection in healthy volunteer blood donors using serological and molecular methods from chaharmahal and Bakhtiari Province, Southwest Iran. Jundishapur J Microbiol. 2019;12(5). e91042. https://doi.org/10.5812/jjm.91042.

  • 22.

    Soltani S, Foroutan M, Afshari H, Hezarian M, Kahvaz MS. Seroepidemiological evaluation of Toxoplasma gondii immunity among the general population in southwest of Iran. J Parasit Dis. 2018;42(4):636-42. [PubMed ID: 30538365]. [PubMed Central ID: PMC6261153]. https://doi.org/10.1007/s12639-018-1047-2.

  • 23.

    Matin S, Shahbazi G, Namin ST, Moradpour R, Feizi F, Piri-Dogahe H. Comparison of Placenta PCR and Maternal Serology of Aborted Women for Detection of Toxoplasma gondii in Ardabil, Iran. Korean J Parasitol. 2017;55(6):607-11. [PubMed ID: 29320815]. [PubMed Central ID: PMC5776894]. https://doi.org/10.3347/kjp.2017.55.6.607.

  • 24.

    Sharif M, Daryani A, Ebrahimnejad Z, Gholami S, Ahmadpour E, Borhani S, et al. Seroprevalence of anti-Toxoplasma IgG and IgM among individuals who were referred to medical laboratories in Mazandaran province, northern Iran. J Infect Public Health. 2016;9(1):75-80. [PubMed ID: 26159578]. https://doi.org/10.1016/j.jiph.2015.06.006.

  • 25.

    Tavakoli Kareshk A, Keyhani A, Asadi A, Zia-Ali N, Mahmoudvand H, Mohammadi AR. Seroprevalence of Toxoplasma gondii infection among childbearing age women in Kerman city, southeastern Iran. J Parasit Dis. 2016;40(4):1544-7. [PubMed ID: 27876979]. [PubMed Central ID: PMC5118350]. https://doi.org/10.1007/s12639-015-0724-7.

  • 26.

    Mojadadi M, Mahmoodabadi N, Sajadiniya Z, Golmohamadi R, Elyasi H. A Seroepidemiological Study of Toxoplasmosis Among Female Students of Sabzevar University of Medical Sciences. Journal of Sabzevar University of Medical Sciences. 2016;23(3):490-5. https://doi.org/10.21859/sums-2303490.

  • 27.

    Kamran M, Esmaeili Rastaghi AR, Amirkhani A, Aghighi Z. [Seroepidemiology and risk factors of toxoplasmosis in high school girls of Ilam in the year 2012]. J Advanced Biomed Sci. 2014;4(3):301-10. FA.

  • 28.

    Saki J, Mohammadpour N, Moramezi F, Khademvatan S. Seroprevalence of Toxoplasma gondii in women who have aborted in comparison with the women with normal delivery in Ahvaz, southwest of Iran. ScientificWorldJournal. 2015;2015:764369. [PubMed ID: 25699288]. [PubMed Central ID: PMC4325198]. https://doi.org/10.1155/2015/764369.

  • 29.

    Hooshyar H, Bagherian T, Heidarzadeh Z, Baghbani F. [Seroprevalence Of Toxoplasmosis In Women Referred To Kashan Reference Laboratory 2008-2012]. Toloo-e-behdasht. 2015;14(1). FA.

  • 30.

    Davami MH, Pourahamd M, Jahromi AR, Tadayon SM. Toxoplasma seroepidemiology in women who intend to marry in Jahrom, Islamic Republic of Iran. East Mediterr Health J. 2014;19 Suppl 3:S71-5. [PubMed ID: 24995764].

  • 31.

    Fallah E, Rasuli A, Shahbazi A, Ghojazadeh M, Khanmohammadi M, Hamzavi F, et al. Seroprevalence of Toxoplasma gondii infection among high school girls in Ajabshir from East Azarbaijan province, Iran. J Caring Sci. 2014;3(3):205-10. [PubMed ID: 25276764]. https://doi.org/10.5681/jcs.2014.022.

  • 32.

    Rajaii M, Pourhassan A, Asle-Rahnamaie-Akbari N, Aghebati L, Xie JL, Goldust M, et al. Seroepidemiology of toxoplasmosis in childbearing women of Northwest Iran. Infez Med. 2013;21(3):194-200. [PubMed ID: 24008851].

  • 33.

    Maraghi S, Yadyad M, Sheikhi M, Latifis M. [Frequency of Anti-Toxoplasma Antibodies in Midwifery and Nursing Students of Abadan Islamic AzadUniversity Students in 2011]. Armaghane Danesh. 2013;18(4):327-9. FA. https://doi.org/10.1080/10854681.2013.11426794.

  • 34.

    Mostafavi N, Ataei B, Nokhodian Z, Monfared LJ, Yaran M, Ataie M, et al. Toxoplasma gondii infection in women of childbearing age of Isfahan, Iran: A population-based study. Adv Biomed Res. 2012;1:60. [PubMed ID: 23326791]. [PubMed Central ID: PMC3544140]. https://doi.org/10.4103/2277-9175.100181.

  • 35.

    Heidari A, Deloie HM, Ghahramani M, Moghaddam MB, Moslem A, Sarshar N, et al. [Seroepidemiological study of toxoplasmosis among high-school girls in Gonabad]. Qom Univ Med Sci J. 2011;5(3):57-63. FA.

  • 36.

    Mostafavi SN, Ataei B, Nokhodian Z, Yaran M, Babak A. Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. J Res Med Sci. 2011;16(4):496-501. [PubMed ID: 22091265]. [PubMed Central ID: PMC3214354].

  • 37.

    Khazaei HA, Narouie B, Bokaeian M, Miri A. Evaluation of IgM against Toxoplasma gondii in under marriage women and its pathogenicity relation with demographic factors. African Journal of Microbiology Research. 2011;5(29):5221-5.

  • 38.

    Hashemi HJ, Saraei M. Seroprevalence of Toxoplasma gondii in unmarried women in Qazvin, Islamic Republic of Iran. East Mediterr Health J. 2010;16(1):24-8. [PubMed ID: 20214153].

  • 39.

    Fouladvand M, Barazesh A, Naeimi B, Zandi K, Tajbakhsh S. Seroprevalence of toxoplasmosis in high school girls in Bushehr city South-west of Iran 2009. Afr J Microbiol Res. 2010;4(11):1117-21.

  • 40.

    Fouladvand M, Barazesh A, Zandi K, Naeimi B, Tajbakhsh S. Seroepidemiological study of toxoplasmosis in childbearing age women in Bushehr City, south west of Iran in 2009. African J Biotech. 2010;9(36):5809-12.

  • 41.

    Foroutan-Rad M, Majidiani H, Dalvand S, Daryani A, Kooti W, Saki J, et al. Toxoplasmosis in Blood Donors: A Systematic Review and Meta-Analysis. Transfus Med Rev. 2016;30(3):116-22. [PubMed ID: 27145927]. https://doi.org/10.1016/j.tmrv.2016.03.002.

  • 42.

    Mizani A, Alipour A, Sharif M, Sarvi S, Amouei A, Shokri A, et al. Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis. Trop Med Health. 2017;45:7. [PubMed ID: 28413330]. [PubMed Central ID: PMC5389165]. https://doi.org/10.1186/s41182-017-0048-7.

  • 43.

    Foroutan M, Majidiani H, Hassanipour S, Badri M. Toxoplasma gondii seroprevalence in the Iranian blood donors: A systematic review and meta-analysis. Heliyon. 2024;10(6). e28013. [PubMed ID: 38509978]. [PubMed Central ID: PMC10951657]. https://doi.org/10.1016/j.heliyon.2024.e28013.

  • 44.

    Saleh MA. Determination of antibodies (IgG, IgM) against Toxoplasma gondii in some Iraqi individuals by using ELISA technique. Baghdad Sci J. 2011;8(4):940-6.

  • 45.

    Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264-96. [PubMed ID: 22491772]. [PubMed Central ID: PMC3346298]. https://doi.org/10.1128/CMR.05013-11.